Takeda Pharmaceutical Other Operating Income or Expenses 2010-2024 | TAK
Takeda Pharmaceutical other operating income or expenses for the twelve months ending June 30, 2024 were $-1.424B, a 54.58% increase year-over-year.
- Takeda Pharmaceutical annual other operating income or expenses for 2024 were $-1.291B, a 45.63% increase from 2023.
- Takeda Pharmaceutical annual other operating income or expenses for 2023 were $-0.887B, a 14.08% decline from 2022.
- Takeda Pharmaceutical annual other operating income or expenses for 2022 were $-1.032B, a 285.68% decline from 2021.